Pristiq Low Dose Shows Benefit In Treating MDD
This article was originally published in The Pink Sheet Daily
Executive Summary
Data on Wyeth’s investigational SNRI was submitted to FDA in August, with action expected in the first quarter.
You may also be interested in...
FDA Clears Wyeth’s Pristiq For Depression
New study in menopausal hot flashes and night sweats is due first half of this year.
FDA Clears Wyeth’s Pristiq For Depression
New study in menopausal hot flashes and night sweats is due first half of this year.
Pristiq Vasomotor Symptoms Indication Set Back Until At Least 2009
Trial to confirm cardiovascular and hepatic safety of the SNRI will take at least 18 months to complete, Wyeth confirms.